Verified stock metrics
Viridian Therapeutics Key Stock Metrics
Direct answer
Viridian Therapeutics has 7 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked September 17, 2026.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $2.54B
- Price-to-book ratio
- 4.56x
- Return on equity
- -65.74%
- 52-week price range
- $13.18 to $34.29
- Revenue growth
- 278.7%
- Profit margin
- 0%
- Debt-to-equity ratio
- 36.96%
Explore related company data
View Viridian Therapeutics's market capitalizationView Viridian Therapeutics's price-to-book ratioView Viridian Therapeutics's return on equityView Viridian Therapeutics's 52-week price rangeView Viridian Therapeutics's revenue growthView Viridian Therapeutics's profit marginView Viridian Therapeutics's debt-to-equity ratioReturn to Viridian Therapeutics profile